Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-11 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.700 | -0.830 | -0.1300 | ||||
REV | 4.810M | 1.734M | -3.076M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
VIR | Vir Biotechnology | 45.18 | 5.51 | 13.89% | 5.8B |
You can purchase shares of Vir Biotechnology (NASDAQ: VIR) through any online brokerage.
Other companies in Vir Biotechnology’s space includes: Twist Bioscience (NASDAQ:TWST), Sarepta Therapeutics (NASDAQ:SRPT) and Sage Therapeutics (NASDAQ:SAGE).
The latest price target for Vir Biotechnology (NASDAQ: VIR) was reported by Needham on 2021-03-02. The analyst firm set a price target for 75.00 expecting VIR to rise to within 12 months (a possible 66.00% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Vir Biotechnology (NASDAQ: VIR) is $45.18 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Vir Biotechnology.
There is no upcoming split for Vir Biotechnology.